Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR
The patented BCTs were developed at
"Our patented blood collection tubes are designed to facilitate the high-growth potential of liquid biopsy, and our agreement with VWR can help us leverage this opportunity in scale," said
About
Forward-Looking Statements Disclaimer Statement
This news release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to be correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend" or "project," or the negative of these words or other variations on these words or comparable terminology. To the extent that statements in this news release are not strictly historical, including, without limitation, statements as to our ability to improve the outcomes of cancer patients, increase revenue or sales, the
utility and effectiveness of our intellectual property protections, and our ability to drive additional value of the Company, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our
View original content with multimedia:http://www.prnewswire.com/news-releases/biocept-enters-into-exclusive-distribution-agreement-with-global-laboratory-product-supplier-vwr-300503561.html
SOURCE
News Provided by Acquire Media